We are a university-launched startup, aiming for the social implementation of a technology developed by Professor Yusuke Ohba of the Department of Cell Physiology, Faculty of Medicine, Hokkaido University, Japan: "Fluorescent Bioimaging-based Drug Efficacy Evaluation Method".
- Company name
- Horizon Illumination Lab Optics, Co. Ltd.
- Establishment date
- August 5, 2021
- Address
- Sapporo, Japan
- President
- Maho AMANO, PhD
- Capital
- ¥97,501,685
- Management Board
- CEO: Maho AMANO, PhD
CTO: Yusuke OHBA, MD, PhD
CFO: Masanori NAKAI
Director: Jun-Ichi ISHII
Our activities are supported by the following.
- Japan Science and Technology Agency (JST) “SCORE” FY2019
- TERUMO LIFE SCIENCE FOUNDATION “R&D subsides” FY2019-2021
- New Energy and Industrial Technology Development Organization (NEDO) “NEP typeB” FY2021
- North Pacific Bank, Ltd. "Dream Foundation" FY2021
- NEDO “STS” FY2022-2023
- AMED “Translational Research Grant preF” FY2023-2024
- Northern Advancement Center for Science ＆ Technology (NOASTEC) "Digital Health Commercialization Support" FY2023 & 2024
- Toshiaki Ogasawara Memorial Foundation "IncuVenture Support" FY2024
- The Hokkaido Bank, Ltd. "Support for Technology Activation of Small and Medium Enterprises" FY2024
- NEDO "Sixth Call for Proposals of NEDO Deep Tech Startup Support Program"